Occult hepatitis B virus infection in Turkish healthy individuals

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 12, 2009, Pages 1436-1437

  Özaslan, Ersan ^a   Demirezer, Aylin ^a   Yavuz, Banu ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

BLOOD DONOR; CLINICAL FEATURE; HEPATITIS B; HUMAN; LABORATORY TEST; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; TURKEY (REPUBLIC);

ADULT; CARRIER STATE; FEMALE; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; TURKEY;

EID: 77950243473     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/10.1097/MEG.0b013e328321b124     Document Type: Letter

References (11)

1. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49:652-657.
2. Michalak TI, Mulrooney PM, Coffin CS. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J Virol 2004; 78:1730-1738.
3. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9:243-257.
4. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 2001; 34:194-203.
5. Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol 2004; 11:18-25.
6. Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, et al. Occult hepatitis B virus infection in a North American community-based population. J Hepatol 2005; 42:480-485.
7. Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008; 48:743-746.
8. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, et al. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007; 47:1162-1171.
9. Sarrecchia C, Cappelli A, Aiello P. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother 2005; 11:189-191.
10. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 136:699-712.
11. Barclay S, Pol S, Mutimer D, Benhamou Y, Mills PR, Hayes PC, et al. The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting. J Clin Virol 2008; 42:104-115.